Antimicrobial resistance or decreased susceptibiity (DS/R) to in Latvia
Latvia: Antimicrobial resistance or decreased susceptibiity (DS/R) to was 7 in 2019. ◆ Volatile
Antimicrobial resistance or decreased susceptibiity (DS/R) to in Latvia, 2009–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, antimicrobial resistance or decreased susceptibiity (ds/r) to in Latvia stood at 7.
Compared with earlier readings it is up 40.0% on the previous year and down 22.2% over ten years.
Over the whole period, antimicrobial resistance or decreased susceptibiity (ds/r) to in Latvia peaked at 39 in 2012 and was at its lowest, 4, in 2017.
Latvia ranks 46th of 54 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antimicrobial resistance or decreased susceptibiity (DS/R) to in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 9 | — |
| 2010 | 20 | +122.2% |
| 2011 | 28 | +40.0% |
| 2012 | 39 | +39.3% |
| 2013 | 38 | -2.6% |
| 2014 | 21 | -44.7% |
| 2015 | 9 | -57.1% |
| 2016 | 8 | -11.1% |
| 2017 | 4 | -50.0% |
| 2018 | 5 | +25.0% |
| 2019 | 7 | +40.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9 | 9 | 9 | 1 |
| 2010s | 17.9 | 4 | 39 | 10 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 60-64, female, annual growth rate -3.24 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0389 units per person (2025)
- Population ages 60-64, male, annual growth rate -2.19 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0308 units per person (2025)
Frequently asked questions
- What is antimicrobial resistance or decreased susceptibiity (ds/r) to in Latvia?
- Antimicrobial resistance or decreased susceptibiity (ds/r) to in Latvia was 7 in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in Latvia?
- The highest recorded value was 39 in 2012.
- What is the lowest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in Latvia?
- The lowest recorded value was 4 in 2017.
- How does Latvia rank for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- Latvia ranks 46th out of 54 countries with data for 2019.
- Is antimicrobial resistance or decreased susceptibiity (ds/r) to rising or falling in Latvia?
- Over the last ten years it is down 22.2%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).